[{"id":"cc779273-45ab-45c8-b571-03dd1632ce79","acronym":"GLB-001-02","url":"https://clinicaltrials.gov/study/NCT06378437","created_at":"2024-04-22T23:49:35.454Z","updated_at":"2024-07-02T16:34:59.114Z","phase":"Phase 1","brief_title":"A Study of GLB-001 in Patients With Myeloid Malignancies","source_id_and_acronym":"NCT06378437 - GLB-001-02","lead_sponsor":"Hangzhou GluBio Pharmaceutical Co., Ltd.","biomarkers":" JAK2","pipe":"","alterations":" ","tags":["JAK2"],"overall_status":"Recruiting","enrollment":" Enrollment 108","initiation":"Initiation: 05/24/2024","start_date":" 05/24/2024","primary_txt":" Primary completion: 12/31/2026","primary_completion_date":" 12/31/2026","study_txt":" Completion: 12/31/2027","study_completion_date":" 12/31/2027","last_update_posted":"2024-06-04"}]